{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:15:09Z","timestamp":1783458909052,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2021\/41\/B\/NZ7\/00328"],"award-info":[{"award-number":["UMO-2021\/41\/B\/NZ7\/00328"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111046","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:01:51Z","timestamp":1779984111000},"page":"111046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interactions between SSR504734, a selective glycine transporter type 1 inhibitor, and antiseizure drugs: pharmacodynamic and pharmacokinetic studies in mice"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-2032","authenticated-orcid":false,"given":"Nikola","family":"Gapi\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-0241","authenticated-orcid":false,"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-0574","authenticated-orcid":false,"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2476-9709","authenticated-orcid":false,"given":"Artur","family":"\u015awierczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-371X","authenticated-orcid":false,"given":"Krzysztof","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6602-3825","authenticated-orcid":false,"given":"Marcin","family":"Jakubiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9100-5979","authenticated-orcid":false,"given":"Katarzyna","family":"Ciepiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9738-3359","authenticated-orcid":false,"given":"Micha\u0142","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9247-2598","authenticated-orcid":false,"given":"Gniewomir","family":"Latacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-3953","authenticated-orcid":false,"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-2080","authenticated-orcid":false,"given":"Katarzyna","family":"Soca\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111046_bib1","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2174\/1570159X19666210826125341","article-title":"Elucidating the potential side effects of Current anti-seizure drugs for epilepsy","volume":"19","author":"Aky\u00fcz","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pnpbp.2012.07.001","article-title":"Effect of ACEA \u2013 a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model","volume":"39","author":"Andres-Mach","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111046_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/09727531231185991","article-title":"Recent progress in the development of new antiepileptic drugs with novel targets","volume":"30","author":"Belete","year":"2023","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BST0340055","article-title":"Glycine transporters: essential regulators of synaptic transmission","volume":"34","author":"Betz","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2026.111046_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.seizure.2020.10.018","article-title":"Current role of carbamazepine and oxcarbazepine in the management of epilepsy","volume":"83","author":"Beydoun","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2026.111046_bib7","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1460-9568.2004.03266.x","article-title":"Characterization of the inhibitory glycine receptor on entorhinal cortex neurons","volume":"19","author":"Breustedt","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1528-1167.2006.00502.x","article-title":"Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures","volume":"47","author":"Brevard","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.111046_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in negative symptoms of schizophrenia-results from the phase III FlashLyte and DayLyte studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111046_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.seizure.2023.03.017","article-title":"Levetiracetam, from broad-spectrum use to precision prescription: a narrative review and expert opinion","volume":"107","author":"Celdran de Castro","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2026.111046_bib11","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00415-023-11834-8","article-title":"Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis","volume":"270","author":"Chu","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13543776.2018.1429408","article-title":"Glycine transporter-1 inhibitors: a patent review (2011-2016)","volume":"28","author":"Cioffi","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111046_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.neuropharm.2026.111046_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.biopha.2018.03.048","article-title":"Participation of the IKK-\u03b1\/\u03b2 complex in the inhibition of the TNF-\u03b1\/NF-\u03baB pathway by glycine: possible involvement of a membrane receptor specific to adipocytes","volume":"102","author":"Contreras-Nu\u00f1ez","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111046_bib15","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.3390\/ijms24076050","article-title":"Understanding lamotrigine's role in the CNS and possible future evolution","volume":"24","author":"Costa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fpsyt.2020.00369","article-title":"Glycine signaling in the framework of dopamine-glutamate interaction and postsynaptic density. Implications for treatment-resistant schizophrenia","volume":"11","author":"de Bartolomeis","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111046_bib17","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","article-title":"Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic","volume":"30","author":"Depoort\u00e8re","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111046_bib18","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3390\/ijms23052561","article-title":"Synergistic control of transmitter turnover at glycinergic synapses by GlyT1, GlyT2, and ASC-1","volume":"23","author":"Eulenburg","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib19","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2026.010101","article-title":"Effect sizes for nonparametric tests","volume":"36","author":"Fiel Peres","year":"2026","journal-title":"Biochem. Med. (Zagreb)"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111046_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/pharmaceutics13020270","article-title":"Pharmacokinetics of the CYP3A4 and CYP2B6 inducer carbamazepine and its drug-drug interaction potential: a physiologically based pharmacokinetic modeling approach","volume":"13","author":"Fuhr","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2026.111046_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/epi4.12490","article-title":"Antiepileptogenesis and disease modification: progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop","volume":"6","author":"Galanopoulou","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2026.111046_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/acschemneuro.5c00039","article-title":"Effect of SSR504734, a selective glycine transporter type 1 inhibitor, on seizure thresholds, neurotransmitter levels, and inflammatory markers in mice","volume":"16","author":"Gapi\u0144ska","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141221","article-title":"Repeated 6-Hz corneal stimulation progressively increases FosB\/\u0394FosB levels in the lateral amygdala and induces seizure generalization to the hippocampus","volume":"10","author":"Giordano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111046_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/npr2.12196","article-title":"Neuropharmacology of antiseizure drugs","volume":"41","author":"Hakami","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111046_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/biom10030464","article-title":"Ionotropic glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors","volume":"10","author":"Hanada","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.111046_bib25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/epi.17235","article-title":"Big data analysis of ASM retention rates and expert ASM algorithm: a comparative study","volume":"63","author":"H\u00e5kansson","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.111046_bib28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fphar.2019.01222","article-title":"Isobologram analysis: a comprehensive review of methodology and Current research","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainres.2010.03.032","article-title":"Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test","volume":"1331","author":"Kalinichev","year":"2010","journal-title":"Brain Res."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111046_bib30","doi-asserted-by":"crossref","first-page":"9582","DOI":"10.3390\/ijms22179582","article-title":"Pharmacokinetic drug-drug interactions among antiepileptic drugs, including CBD, drugs used to treat COVID-19 and nutrients","volume":"22","author":"Kara\u017aniewicz-\u0141ada","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s11064-017-2275-z","article-title":"The National Institute of Neurological disorders and stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)","volume":"42","author":"Kehne","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib32","series-title":"Drug-Like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization","author":"Kerns","year":"2010"},{"key":"10.1016\/j.neuropharm.2026.111046_bib33","series-title":"Experimental and Translational Methods to Screen Drugs Effective Against Seizures and Epilepsy","article-title":"Protocol for 6 Hz corneal stimulation in rodents for refractory seizures","author":"Khanam","year":"2021"},{"key":"10.1016\/j.neuropharm.2026.111046_bib34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","article-title":"New epilepsy therapies in development","volume":"23","author":"Klein","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111046_bib36","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1111\/epi.18607","article-title":"Real-world comparison of first-line antiseizure monotherapy and the role of age at treatment initiation in newly diagnosed childhood epilepsy: a cohort study from a tertiary center","volume":"66","author":"Li","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.111046_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111046_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-Target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy","volume":"12","author":"L\u00f6scher","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib38","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2026.111046_bib39","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s11064-016-2025-7","article-title":"The search for new screening models of pharmacoresistant epilepsy: is induction of acute seizures in epileptic rodents a suitable approach?","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1528-1167.2006.00964.x","article-title":"Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model","volume":"48","author":"Luszczki","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.111046_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","article-title":"Native glycine receptor subtypes and their physiological roles","volume":"56","author":"Lynch","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2020.07.025","article-title":"Neurobiology of glycine transporters: from molecules to behavior","volume":"118","author":"Marques","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111046_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0091-3057(01)00466-X","article-title":"Sex differences in sensitivity to seizures elicited by pentylenetetrazol in mice","volume":"68","author":"Medina","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111046_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120766","article-title":"Drug-resistant epilepsy: definition, pathophysiology, and management","volume":"452","author":"Mesraoua","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00702-012-0767-1","article-title":"Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice","volume":"119","author":"Nieoczym","year":"2012","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neuropharm.2026.111046_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111046_bib49","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1007\/s12325-023-02586-y","article-title":"Narrative review of topiramate: clinical uses and pharmacological considerations","volume":"40","author":"Pearl","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.neuropharm.2026.111046_bib50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0028-3908(86)90109-7","article-title":"Glycine potentiates the anticonvulsant action of diazepam and phenobarbital in kindled amygdaloid seizures of rats","volume":"25","author":"Peterson","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(91)90498-F","article-title":"Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid","volume":"199","author":"Peterson","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib52","series-title":"Neuropharmacology Methods in Epilepsy Research","article-title":"Electroshock","author":"Peterson","year":"1998"},{"key":"10.1016\/j.neuropharm.2026.111046_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0028-3908(90)90100-6","article-title":"Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats","volume":"29","author":"Peterson","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0361-9230(87)90206-1","article-title":"Glycine potentiates diazepam anticonvulsant activity in electroshock seizures of rats: possible sites of interaction in the brainstem","volume":"18","author":"Peterson","year":"1987","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111046_bib55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00213-025-06915-7","article-title":"Modulation of glycine transporters as a novel therapeutic strategy in neuropsychiatry","volume":"243","author":"Pinna","year":"2025","journal-title":"Psychopharmacology (Berl.)."},{"key":"10.1016\/j.neuropharm.2026.111046_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.12.007","article-title":"Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats","volume":"58","author":"Potschka","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/pediatric13040078","article-title":"Therapeutic options for childhood absence epilepsy","volume":"13","author":"Rinaldi","year":"2021","journal-title":"Pediatr. Rep."},{"key":"10.1016\/j.neuropharm.2026.111046_bib58","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00406-023-01576-z","article-title":"Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia","volume":"273","author":"Rosenbrock","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2026.111046_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.07.004","article-title":"Sex differences in the neurobiology of epilepsy: a preclinical perspective","volume":"72","author":"Scharfman","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.111046_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0306-3623(84)90018-1","article-title":"Synergistic anticonvulsant effects of a GABA agonist and glycine","volume":"15","author":"Seiler","year":"1984","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.neuropharm.2015.08.031","article-title":"Glycine transporter 1 is a target for the treatment of epilepsy","volume":"99","author":"Shen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fnmol.2020.00097","article-title":"Sarcosine suppresses epileptogenesis in rats with effects on hippocampal DNA methylation","volume":"13","author":"Shen","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: a new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111046_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nurt.2006.11.009","article-title":"Discovery of antiepileptic drugs","volume":"4","author":"Smith","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111046_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.04.010","article-title":"Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice","volume":"326","author":"Soca\u0142a","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12640-018-9876-4","article-title":"Effect of Tadalafil on seizure threshold and activity of antiepileptic drugs in three acute seizure tests in mice","volume":"34","author":"Soca\u0142a","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2026.111046_bib65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1734-1140(10)70279-6","article-title":"Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models","volume":"62","author":"Soca\u0142a","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2026.111046_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107733","article-title":"Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: pharmacodynamic and pharmacokinetic studies","volume":"158","author":"Soca\u0142a","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40263-020-00698-5","article-title":"Pharmacological management of the genetic generalised epilepsies in adolescents and adults","volume":"34","author":"Stephen","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2026.111046_bib70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1745-7254.2006.00246.x","article-title":"Transport of carbamazepine and drug interactions at blood-brain barrier","volume":"27","author":"Sun","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.111046_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2023.04.010","article-title":"Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia","volume":"256","author":"Surti","year":"2023","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2026.111046_bib72","first-page":"S133","article-title":"Antiseizure medication discovery: recent and future paradigm shifts","volume":"7","author":"Talevi","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2026.111046_bib73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00207450108986513","article-title":"Sex difference in susceptibility to epileptic seizures in rats: importance of estrous cycle","volume":"108","author":"Tan","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111046_bib74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1208\/s12248-024-00978-8","article-title":"UGT2B10 is the major UDP-Glucuronosyltransferase 2B isoform involved in the metabolism of Lamotrigine and is implicated in the drug-drug interaction with valproic acid","volume":"26","author":"Tang","year":"2024","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2026.111046_bib75","series-title":"Bioanalytical Method Validation: Guidance for Industry","year":"2018"},{"key":"10.1016\/j.neuropharm.2026.111046_bib76","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.7150\/thno.56331","article-title":"Female mice lacking ER\u03b2 display excitatory\/inhibitory synaptic imbalance to drive the pathogenesis of temporal lobe epilepsy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2026.111046_bib77","series-title":"Neuropharmacology Methods in Epilepsy Research","article-title":"Chemoconvulsants","author":"White","year":"1998"},{"key":"10.1016\/j.neuropharm.2026.111046_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2010.04.008","article-title":"Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation","volume":"91","author":"Xu","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib79","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1152\/jn.00287.2010","article-title":"NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms","volume":"105","author":"Xue","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-319-55769-4_4","article-title":"Glycine transporters and its coupling with NMDA receptors","volume":"16","author":"Zafra","year":"2017","journal-title":"Adv.Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111046_bib81","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.npp.1301449","article-title":"Glycine uptake regulates hippocampal network activity via glycine receptor-mediated tonic inhibition","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111046_bib82","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1248\/bpb.b15-00501","article-title":"A highly selective inhibitor of glycine Transporter-1 elevates the threshold for maximal electroshock-induced tonic seizure in mice","volume":"39","author":"Zhao","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2026.111046_bib83","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00213-015-3884-3","article-title":"Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"232","author":"Zolkowska","year":"2015","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:31:04Z","timestamp":1783456264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":81,"alternative-id":["S0028390826002200"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111046","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between SSR504734, a selective glycine transporter type 1 inhibitor, and antiseizure drugs: pharmacodynamic and pharmacokinetic studies in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111046"}}